Lam Research Corporation $LRCX Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. decreased its stake in Lam Research Corporation (NASDAQ:LRCX) by 16.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,315,029 shares of the semiconductor company’s stock after selling 5,125,168 shares during the period. Lam Research makes up 0.8% of Ameriprise Financial Inc.’s investment portfolio, making the stock its 12th largest holding. Ameriprise Financial Inc. owned 2.02% of Lam Research worth $3,389,852,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in LRCX. Howard Hughes Medical Institute purchased a new position in Lam Research in the second quarter valued at about $27,000. Sound Income Strategies LLC purchased a new position in Lam Research in the 3rd quarter valued at approximately $41,000. Tripletail Wealth Management LLC acquired a new position in Lam Research during the third quarter worth $44,000. Strategic Wealth Investment Group LLC purchased a new stake in Lam Research during the second quarter worth $29,000. Finally, Delos Wealth Advisors LLC acquired a new stake in Lam Research in the second quarter valued at $30,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Performance

Shares of LRCX opened at $212.20 on Friday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $256.68. The company’s 50 day simple moving average is $224.75 and its 200 day simple moving average is $173.18. The company has a market capitalization of $264.99 billion, a price-to-earnings ratio of 43.48, a PEG ratio of 2.28 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.61 and a current ratio of 2.26.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the company earned $0.91 EPS. Lam Research’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s dividend payout ratio is 21.31%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on LRCX shares. Barclays lifted their price target on Lam Research from $250.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 10th. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research report on Monday, December 29th. Rothschild & Co Redburn increased their price target on shares of Lam Research from $225.00 to $265.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Morgan Stanley lifted their price objective on Lam Research from $244.00 to $254.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 25th. Finally, Susquehanna set a $325.00 target price on Lam Research and gave the company a “positive” rating in a report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and an average target price of $245.35.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the transaction, the chief financial officer directly owned 1,081,705 shares in the company, valued at $242,334,371.15. This represents a 4.42% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 130,886 shares of company stock valued at $29,658,802. Insiders own 0.31% of the company’s stock.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam is engaging with BE Semiconductor Industries (BESI) to boost advanced‑packaging capabilities and content — a strategic M&A angle that would accelerate Lam’s exposure to fast‑growing advanced packaging markets. Lam Research BESI Talks Highlight Push Into Advanced Packaging Content — Also reported that BESI has drawn takeover interest with Lam among suitors. Exclusive‑BESI attracts takeover interest as advanced chip packaging demand surges
• Positive Sentiment: Lam and IBM announced a long‑term collaboration to develop processes/materials for sub‑1nm logic and High‑NA EUV — strengthening Lam’s roadmap exposure to next‑gen logic and AI chips. Lam Research IBM Alliance Targets Sub 1nm Logic And AI Chip Demand
• Positive Sentiment: Management is targeting growth in foundry and logic markets and is aiming for gross margins above 50% via pricing and mix — a direct driver of EPS leverage if demand stays strong. Lam Research Corp. (LRCX) Targets Growth in Foundry and Logic Markets
• Positive Sentiment: Analysts have lifted targets and reiterated conviction after solid results and outlook; Barclays raised its price target recently (supportive to near‑term sentiment). Is Lam Research One of the Best Large‑Cap Tech Stocks to Invest In?
• Positive Sentiment: Industry analysis highlights a supply‑constrained WFE cycle and strong AI/advanced‑packaging demand that underpin a multi‑year capex runway for Lam. Lam Research: Supply‑Constrained WFE Cycle Sets Up A Multi‑Year Runway
• Neutral Sentiment: Market momentum: LRCX has rallied ~33% over three months on earnings beats and AI/packaging demand—helpful context but not a new catalyst. LRCX Stock Soars 33% in Three Months
• Negative Sentiment: Valuation concerns: some analysts/commentaries warn the stock may be extended and expect a re‑rating or consolidation — a risk if WFE momentum or execution disappoints. Lam Research: Wonderful Company, But The Price Needs To Come Back To Earth

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.